Literature DB >> 7556241

Detection of hepatitis B virus DNA in chronic carriers of hepatitis B surface antigen in southwestern Greece.

M Christofidou1, A Athanassiadou, A Skoutelis, E D Anastassiou.   

Abstract

The presence of hepatitis B virus (HBV) DNA in sera of 56 chronic carriers of hepatitis B surface antigen (HBsAg) was determined by three methods: the Abbott hybridization assay, the polymerase chain reaction (PCR) followed by gel electrophoresis and UV visualization (PCR-GE), and PCR followed by DNA enzyme immunoassay (PCR-DEIA). HBV DNA was detected in four samples positive for hepatitis Be antigen (HBeAg) by all methods used. Both PCR-GE and PCR-DEIA detected viraemia in two anti-HBe, anti-HBc IgM positive samples. In the group of 50 anti-HBe positive samples the sensitivity of the three methods was 10%, 24% and 32%, respectively. PCR-GE and PCR-DEIA results correlated well with the patients' clinical status; of 20 patients with elevated ALT levels, 12 (60%) were found to be positive in the PCR-GE and another 2 were found to be positive in the PCR-DEIA (70%). These data indicate that PCR-DEIA is the most sensitive method for detection of HBV DNA. This method can be relatively easily applied in the clinical laboratory for monitoring the progression of disease and/or interferon therapy in patients with chronic hepatitis B.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556241     DOI: 10.1007/bf02114908

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

1.  Analysis of amplified T cell receptor V beta transcripts by a non-isotopic immunoassay.

Authors:  A Bettinardi; L Imberti; A Sottini; D Primi
Journal:  J Immunol Methods       Date:  1992-01-21       Impact factor: 2.303

Review 2.  Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association.

Authors:  W Szmuness
Journal:  Prog Med Virol       Date:  1978

3.  Detection of hepatitis B virus DNA in serum by polymerase chain reaction amplification and microtiter sandwich hybridization.

Authors:  G H Keller; D P Huang; J W Shih; M M Manak
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

4.  Detection of hepatitis B virus DNA in serum by a rapid filtration-hybridization assay.

Authors:  G Morace; K von der Helm; W Jilg; F Deinhardt
Journal:  J Virol Methods       Date:  1985-12       Impact factor: 2.014

5.  Determination of hepatitis B virus DNA in serum using the polymerase chain reaction: clinical significance and correlation with serological and biochemical markers.

Authors:  B L Baker; A M Di Bisceglie; S Kaneko; R Miller; S M Feinstone; J G Waggoner; J H Hoofnagle
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425

6.  DNA enzyme immunoassay: general method for detecting products of polymerase chain reaction.

Authors:  G Mantero; A Zonaro; A Albertini; P Bertolo; D Primi
Journal:  Clin Chem       Date:  1991-03       Impact factor: 8.327

7.  Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.

Authors:  S J Hadziyannis; H M Lieberman; G G Karvountzis; D A Shafritz
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

8.  Comparison of methods for detection of hepatitis B virus DNA.

Authors:  H L Zaaijer; F ter Borg; H T Cuypers; M C Hermus; P N Lelie
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

9.  Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver.

Authors:  F Bonino; B Hoyer; J Nelson; R Engle; G Verme; J Gerin
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

10.  Suppression of the inhibitory effect of denatured albumin on the polymerase chain reaction by sodium octanoate: application to routine clinical detection of hepatitis B virus at its infectivity threshold in serum.

Authors:  C Vandenvelde; R Scheen; M Defoor; M Duys; J Dumon; D Van Beers
Journal:  J Virol Methods       Date:  1993-05       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.